ARK Invest
Private EquityInvestment management firm founded by Cathie Wood, focused on disruptive innovation including robotics, AI, and genomics.
Profile
Capital
Portfolio
4 companiesThe first federally regulated prediction market exchange in the United States, approved by the CFTC as a Designated Contract Market in 2020. Enables users to trade event contracts on real-world outcomes spanning economics, politics, weather, sports, and culture. Emerged from Y Combinator's W19 batch.
Biotech company developing AI-powered multiomics blood tests for early cancer detection. Its platform analyzes cell-free DNA, methylation patterns, and protein biomarkers from routine blood draws to screen for cancers in their earliest stages. Lead product SimpleScreen targets FDA approval for colorectal cancer screening.
Defense technology company building autonomous AI pilot software and unmanned aircraft systems. Its flagship Hivemind software enables teams of aircraft to execute missions autonomously without GPS, communications, or remote pilots. Also develops the Nova quadcopter and V-BAT vertical takeoff drone.
Humanoid robotics company building the Apollo general-purpose robot for manufacturing, logistics, and retail. Spun out of the University of Texas Human Centered Robotics Lab in 2016.
Investment data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.